(RPRX) Royalty Pharma - Performance 34.8% in 12m
RPRX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-15.76%
#78 in Peer-Group
Rel. Strength
81.07%
#1441 in Stock-Universe
Total Return 12m
34.81%
#28 in Peer-Group
Total Return 5y
-12.49%
#78 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 13.6 |
| P/E Forward | 11.2 |
| High / Low | USD |
|---|---|
| 52 Week High | 35.27 USD |
| 52 Week Low | 23.96 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 87.31 |
| Buy/Sell Signal +-5 | -0.85 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RPRX (34.8%) vs XLV (-5.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-4.5% | 145% | 360% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
12% | -6.78% | 514% | 66.1 | 37 | 1.24 | 58.2% | 18.9% |
| NVS NYSE Novartis |
10.1% | 17.9% | 81.6% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
7.55% | 7.58% | 54.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| SFZN SW Siegfried Holding |
-0.63% | 2.28% | 140% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| GSK NYSE GlaxoSmithKline |
10% | 4.92% | 57.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
9.51% | -4.27% | 58.6% | 28.9 | 15.9 | 0.96 | 52.7% | 22.3% |
| IPN PA Ipsen |
2.14% | -13% | 54.2% | 24.4 | 10.3 | 0.74 | -6.40% | -6.33% |
Performance Comparison: RPRX vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for RPRX
| Total Return (including Dividends) | RPRX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 5.90% | 4.35% | 1.11% |
| 3 Months | 6.22% | -6.89% | 5.58% |
| 12 Months | 34.81% | -5.08% | 10.51% |
| 5 Years | -12.49% | 50.53% | 109.12% |
| Trend Score (consistency of price movement) | RPRX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 50.9% | 65.8% | 69.9% |
| 3 Months | 52.6% | -72% | 69.3% |
| 12 Months | 71% | -62.2% | 43.2% |
| 5 Years | -76.9% | 88.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #86 | 1.49% | 4.74% |
| 3 Month | #71 | 14.08% | 0.60% |
| 12 Month | #28 | 42.03% | 21.99% |
| 5 Years | #83 | -40.44% | -57.35% |
FAQs
Does Royalty Pharma (RPRX) outperform the market?
Yes,
over the last 12 months RPRX made 34.81%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%.
Over the last 3 months RPRX made 6.22%, while XLV made -6.89%.
Performance Comparison RPRX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RPRX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 4.8% | 4.8% | 42.2% | 24% |
| US NASDAQ 100 | QQQ | 5% | 4.4% | 43% | 26% |
| German DAX 40 | DAX | 7% | 6.7% | 25.9% | 5% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 5.1% | 6.8% | 40.4% | 23% |
| Hongkong Hang Seng | HSI | 4.3% | 0.9% | 23.2% | 7% |
| India NIFTY 50 | INDA | 6.5% | 7.2% | 43.2% | 36% |
| Brasil Bovespa | EWZ | 2.5% | 5.4% | 22% | 26% |
RPRX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 5.1% | 4.4% | 39.4% | 12% |
| Consumer Discretionary | XLY | 5.3% | 7.7% | 52.1% | 17% |
| Consumer Staples | XLP | 5.1% | 6.1% | 40.7% | 28% |
| Energy | XLE | -1.1% | 3% | 38.6% | 32% |
| Financial | XLF | 6.4% | 8.5% | 39.4% | 11% |
| Health Care | XLV | 2.9% | 1.6% | 42.7% | 40% |
| Industrial | XLI | 5.8% | 5.6% | 36.7% | 17% |
| Materials | XLB | 5.5% | 4.5% | 41.4% | 35% |
| Real Estate | XLRE | 4.3% | 4.9% | 41.2% | 22% |
| Technology | XLK | 4.5% | 3.9% | 41.8% | 31% |
| Utilities | XLU | 3.4% | 5.4% | 33.9% | 14% |
| Aerospace & Defense | XAR | 5.8% | 0.1% | 25.3% | -8% |
| Biotech | XBI | 5.1% | -1.9% | 53% | 42% |
| Homebuilder | XHB | 6.4% | 10.9% | 57.6% | 44% |
| Retail | XRT | 8.7% | 6.1% | 50.2% | 34% |
RPRX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -7% | -12.8% | 32.4% | 32% |
| Natural Gas | UNG | 5.6% | 8.5% | 23.9% | 49% |
| Gold | GLD | 1.2% | -0.3% | 12.1% | -13% |
| Silver | SLV | 5.6% | -5.5% | 22.6% | 12% |
| Copper | CPER | 7.3% | 4.2% | 27.3% | 26% |
RPRX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3.3% | 5.2% | 43.7% | 39% |
| iShares High Yield Corp. Bond | HYG | 4.3% | 5.4% | 38.5% | 26% |